The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transdermal Testosterone Market Research Report 2024
Synopsis
Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels.
The global Transdermal Testosterone market was valued at US$ 589 million in 2023 and is anticipated to reach US$ 923.9 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
North American market for Transdermal Testosterone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Testosterone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Transdermal Testosterone include AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories and Allergan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transdermal Testosterone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Testosterone.
Report Scope
The Transdermal Testosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Testosterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Testosterone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy's Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.
Segment by Type
Gel
Patch
Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal Testosterone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal Testosterone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels.
The global Transdermal Testosterone market was valued at US$ 589 million in 2023 and is anticipated to reach US$ 923.9 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
North American market for Transdermal Testosterone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Testosterone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Transdermal Testosterone include AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories and Allergan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transdermal Testosterone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Testosterone.
Report Scope
The Transdermal Testosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Testosterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Testosterone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy's Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.
Segment by Type
Gel
Patch
Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal Testosterone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal Testosterone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Transdermal Testosterone Market Overview
1.1 Product Overview and Scope of Transdermal Testosterone
1.2 Transdermal Testosterone Segment by Type
1.2.1 Global Transdermal Testosterone Market Value Comparison by Type (2024-2030)
1.2.2 Gel
1.2.3 Patch
1.3 Transdermal Testosterone Segment by Application
1.3.1 Global Transdermal Testosterone Market Value by Application: (2024-2030)
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Global Transdermal Testosterone Market Size Estimates and Forecasts
1.4.1 Global Transdermal Testosterone Revenue 2019-2030
1.4.2 Global Transdermal Testosterone Sales 2019-2030
1.4.3 Global Transdermal Testosterone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Transdermal Testosterone Market Competition by Manufacturers
2.1 Global Transdermal Testosterone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Transdermal Testosterone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Transdermal Testosterone Average Price by Manufacturers (2019-2024)
2.4 Global Transdermal Testosterone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Testosterone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Testosterone, Product Type & Application
2.7 Transdermal Testosterone Market Competitive Situation and Trends
2.7.1 Transdermal Testosterone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transdermal Testosterone Players Market Share by Revenue
2.7.3 Global Transdermal Testosterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal Testosterone Retrospective Market Scenario by Region
3.1 Global Transdermal Testosterone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Transdermal Testosterone Global Transdermal Testosterone Sales by Region: 2019-2030
3.2.1 Global Transdermal Testosterone Sales by Region: 2019-2024
3.2.2 Global Transdermal Testosterone Sales by Region: 2025-2030
3.3 Global Transdermal Testosterone Global Transdermal Testosterone Revenue by Region: 2019-2030
3.3.1 Global Transdermal Testosterone Revenue by Region: 2019-2024
3.3.2 Global Transdermal Testosterone Revenue by Region: 2025-2030
3.4 North America Transdermal Testosterone Market Facts & Figures by Country
3.4.1 North America Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Transdermal Testosterone Sales by Country (2019-2030)
3.4.3 North America Transdermal Testosterone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transdermal Testosterone Market Facts & Figures by Country
3.5.1 Europe Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Transdermal Testosterone Sales by Country (2019-2030)
3.5.3 Europe Transdermal Testosterone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Testosterone Market Facts & Figures by Country
3.6.1 Asia Pacific Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Transdermal Testosterone Sales by Country (2019-2030)
3.6.3 Asia Pacific Transdermal Testosterone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transdermal Testosterone Market Facts & Figures by Country
3.7.1 Latin America Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Transdermal Testosterone Sales by Country (2019-2030)
3.7.3 Latin America Transdermal Testosterone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Testosterone Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Transdermal Testosterone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Transdermal Testosterone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Testosterone Sales by Type (2019-2030)
4.1.1 Global Transdermal Testosterone Sales by Type (2019-2024)
4.1.2 Global Transdermal Testosterone Sales by Type (2025-2030)
4.1.3 Global Transdermal Testosterone Sales Market Share by Type (2019-2030)
4.2 Global Transdermal Testosterone Revenue by Type (2019-2030)
4.2.1 Global Transdermal Testosterone Revenue by Type (2019-2024)
4.2.2 Global Transdermal Testosterone Revenue by Type (2025-2030)
4.2.3 Global Transdermal Testosterone Revenue Market Share by Type (2019-2030)
4.3 Global Transdermal Testosterone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Transdermal Testosterone Sales by Application (2019-2030)
5.1.1 Global Transdermal Testosterone Sales by Application (2019-2024)
5.1.2 Global Transdermal Testosterone Sales by Application (2025-2030)
5.1.3 Global Transdermal Testosterone Sales Market Share by Application (2019-2030)
5.2 Global Transdermal Testosterone Revenue by Application (2019-2030)
5.2.1 Global Transdermal Testosterone Revenue by Application (2019-2024)
5.2.2 Global Transdermal Testosterone Revenue by Application (2025-2030)
5.2.3 Global Transdermal Testosterone Revenue Market Share by Application (2019-2030)
5.3 Global Transdermal Testosterone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Transdermal Testosterone Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Transdermal Testosterone Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Perrigo
6.3.1 Perrigo Corporation Information
6.3.2 Perrigo Description and Business Overview
6.3.3 Perrigo Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Perrigo Transdermal Testosterone Product Portfolio
6.3.5 Perrigo Recent Developments/Updates
6.4 Endo Pharmaceuticals
6.4.1 Endo Pharmaceuticals Corporation Information
6.4.2 Endo Pharmaceuticals Description and Business Overview
6.4.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Endo Pharmaceuticals Transdermal Testosterone Product Portfolio
6.4.5 Endo Pharmaceuticals Recent Developments/Updates
6.5 Acerus Pharmaceuticals
6.5.1 Acerus Pharmaceuticals Corporation Information
6.5.2 Acerus Pharmaceuticals Description and Business Overview
6.5.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Acerus Pharmaceuticals Transdermal Testosterone Product Portfolio
6.5.5 Acerus Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lupin Transdermal Testosterone Product Portfolio
6.6.5 Lupin Recent Developments/Updates
6.7 Dr. Reddy's Laboratories
6.6.1 Dr. Reddy's Laboratories Corporation Information
6.6.2 Dr. Reddy's Laboratories Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dr. Reddy's Laboratories Transdermal Testosterone Product Portfolio
6.7.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.8 Upsher-Smith Laboratories
6.8.1 Upsher-Smith Laboratories Corporation Information
6.8.2 Upsher-Smith Laboratories Description and Business Overview
6.8.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Upsher-Smith Laboratories Transdermal Testosterone Product Portfolio
6.8.5 Upsher-Smith Laboratories Recent Developments/Updates
6.9 Allergan
6.9.1 Allergan Corporation Information
6.9.2 Allergan Description and Business Overview
6.9.3 Allergan Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Allergan Transdermal Testosterone Product Portfolio
6.9.5 Allergan Recent Developments/Updates
6.10 Cipla Inc.
6.10.1 Cipla Inc. Corporation Information
6.10.2 Cipla Inc. Description and Business Overview
6.10.3 Cipla Inc. Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cipla Inc. Transdermal Testosterone Product Portfolio
6.10.5 Cipla Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Testosterone Industry Chain Analysis
7.2 Transdermal Testosterone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Testosterone Production Mode & Process
7.4 Transdermal Testosterone Sales and Marketing
7.4.1 Transdermal Testosterone Sales Channels
7.4.2 Transdermal Testosterone Distributors
7.5 Transdermal Testosterone Customers
8 Transdermal Testosterone Market Dynamics
8.1 Transdermal Testosterone Industry Trends
8.2 Transdermal Testosterone Market Drivers
8.3 Transdermal Testosterone Market Challenges
8.4 Transdermal Testosterone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
